Showing results (331-340 of 9,898) with videos related to

Sort By:
Pageof 990
Bone Marrow Transplantation|February 3, 2022
Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remissionAlfadil Haroon, Feras Alfraih, Amr Hanbali, et al.
Bone Marrow Transplantation|February 20, 2022
An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous HctAna Belén Moreno-Castaño, Marta Palomo, Sergi Torramadé-Moix, et al.
Bone Marrow Transplantation|February 23, 2022
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity surveyJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.
Bone Marrow Transplantation|June 5, 2019
Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMTTapani Ruutu, Steffie van der Werf, Anja van Biezen, et al.
Bone Marrow Transplantation|October 18, 2019
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseasesKevin Hendrawan, Malini Visweswaran, David D F Ma, et al.
Bone Marrow Transplantation|May 16, 2019
Cord blood research, banking, and transplantation: achievements, challenges, and perspectivesHector Mayani, John E Wagner, Hal E Broxmeyer
Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Bone Marrow Transplantation|April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
Bone Marrow Transplantation|April 28, 2022
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosisMariam T Nawas, Jeong-Ok Lee, Jessica Flynn, et al.
Bone Marrow Transplantation|April 19, 2022
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access programMark A Schroeder, Parameswaran N Hari, Amy Blithe, et al.
Pageof 990